Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Program (U19)

The summary for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Program (U19) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Program (U19): -The purpose of IPCAVD program is to support the more advanced stages of vaccine research and development including: advanced stage preclinical research, such as vaccine optimization studies; Good Laboratory Practice (GLP) preclinical toxicology and safety studies; Good Manufacturing Practice vaccine production; pre-Investigational New Drug (IND) and IND submission; and clinical testing. The manufacture of vaccine product and the initiation of human studies over the duration of the award must be a feasible and established goal. -In FY 2007 and FY 2008, NIAID expects to award a total of $4 million to support the IPCAVD Program. -NIAID anticipates making 1-2 awards per year. -This initiative will be funded using the multi-project Cooperative Agreement (U19) award mechanism. -Eligible organizations include for-profit organizations, non-profit organizations, public or private institutions such as universities, colleges, hospitals, and laboratories; units of State government, and units of local government, eligible agencies of the Federal government, foreign institutions, domestic institutions, and faith-based or community-based organizations. -Eligible Principal Investigators include any individual with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. -An Institution may submit only one application annually; however, applications may include investigators from more than one institution if such arrangements enhance the scientific strength of the proposed research program. In addition, a Principal Investigator may serve as a Project Leader in another multi-project application if there is no scientific overlap with the application submitted by the Principal Investigator.